Teradata reported extraordinary 310% revenue growth from $526M to $2.2B while simultaneously pivoting its strategic narrative toward autonomous AI and agentic enterprise solutions.
This massive revenue surge suggests either a major acquisition, significant business transformation, or accounting change that fundamentally alters Teradata's scale and market position. The concurrent shift from traditional "trusted information" messaging to cutting-edge "agentic AI" and "autonomous AI platform" language indicates management is positioning the company for the next wave of enterprise AI adoption, which could justify premium valuations if execution succeeds.
Teradata delivered exceptional financial performance with revenue exploding 310% to $2.2B while maintaining profitability discipline—net income grew a solid 14% and SG&A expenses actually declined 11%, demonstrating impressive operational leverage. The company strengthened its balance sheet significantly with stockholders' equity up 73% and cash increasing 17% to $493M, while management showed confidence by continuing share buybacks albeit at a reduced $140M level. The overall picture suggests a company that has dramatically expanded its revenue base while maintaining financial discipline and building a stronger foundation for future growth.
Strong top-line growth of 309.9% — accelerating demand or successful expansion into new markets.
Equity base grew 72.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Buyback activity reduced 34.9% — capital being redeployed elsewhere or cash conservation underway.
Inventory reduced 27.8% — lean inventory management or demand outpacing supply.
Interest costs rose 25% — monitor debt levels and coverage ratio in rising rate environment.
Capex reduced 20.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Cash grew 17.4% — improving liquidity position supports investment and shareholder returns.
Net income grew 14% — bottom-line growth signals improving overall business health.
Current assets grew 11.7% — improving short-term liquidity or inventory/receivables build.
SG&A reduced 11.2% — improved cost efficiency or headcount reduction improving operating margins.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →